Recent developments of interest in cardiovascular medicine
The level of cancer-causing N-nitrosodimethylamine (NDMA) in recalled valsartan products and other angiotensin II receptor blockers was as high as 17 mcg per tablet, an FDA analysis found. The government considers up to to 0.096 mcg/day "reasonably safe for human ingestion based on lifetime exposure."